AELIS FARMA SAS (AELIS.PA) Forecast, Price Target & Analyst Ratings

EPA:AELISFR0014007ZB4

Current stock price

1.27 EUR
-0.03 (-2.31%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AELIS FARMA SAS (AELIS.PA).

Forecast Snapshot

Consensus Price Target

Price Target
€11.22
+ 783.46% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
N/A

ChartMill Buy Consensus

Rating
84.44%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
€11.22
Upside
+ 783.46%
From current price of €1.27 to mean target of €11.22, Based on 9 analyst forecasts
Low
€11.11
Median
€11.22
High
€11.55

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for AELIS.PA. The average price target is 11.22 EUR. This implies a price increase of 783.46% is expected in the next year compared to the current price of 1.27.

Analyst Ratings & History

Current Analyst Ratings

AELIS Current Analyst RatingAELIS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

AELIS Historical Analyst RatingsAELIS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.44%
AELIS.PA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about AELIS.PA.
In the previous month the buy percentage consensus was at a similar level.
AELIS.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates 2025 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
AELIS.PA revenue by date.AELIS.PA revenue by date.
3.809M
-58.03%
9.054M
137.70%
2.678M
-70.42%
3.399M
26.92%
12.772M
275.76%
48.093M
276.55%
EBITDA
YoY % growth
AELIS.PA ebitda by date.AELIS.PA ebitda by date.
-8.455M
-426.70%
-6.293M
25.57%
-7.467M
-18.66%
-6.18M
17.24%
2.884M
146.67%
40.702M
1,311.30%
EBIT
YoY % growth
AELIS.PA ebit by date.AELIS.PA ebit by date.
-8.525M
-434.05%
-6.461M
24.21%
-7.735M
-19.72%
-6.386M
17.44%
2.678M
141.94%
40.505M
1,412.51%
Operating Margin
AELIS.PA operating margin by date.AELIS.PA operating margin by date.
-223.81%-71.36%-288.83%-187.88%20.97%84.22%
EPS
YoY % growth
AELIS.PA eps by date.AELIS.PA eps by date.
N/AN/A
0.60%
N/A
67.24%
-0.45
-131.58%
0.18
138.64%
2.54
1,352.12%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AELIS.PA Yearly Revenue VS EstimatesAELIS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
AELIS.PA Yearly EPS VS EstimatesAELIS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 1 2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
146.58%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
88.24%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
152.58%
EBIT Next 5 Year
N/A

AELIS FARMA SAS / AELIS.PA Forecast FAQ

Can you provide the average price target for AELIS FARMA SAS stock?

9 analysts have analysed AELIS.PA and the average price target is 11.22 EUR. This implies a price increase of 783.46% is expected in the next year compared to the current price of 1.27.

What is the consensus rating for AELIS stock?

The consensus rating for AELIS FARMA SAS (AELIS.PA) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.